Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

NCT06539624 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Fabry Disease

Interventions

GENETIC: EXG110 injection

Sponsor

The Children's Hospital of Zhejiang University School of Medicine